Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 30, 2021 - Issue 11
Submit an article Journal homepage
454
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Single and multiple dose pharmacokinetics and safety of ZSP1273, an RNA polymerase PB2 protein inhibitor of the influenza A virus: a phase 1 double-blind study in healthy subjects

Yue Hua Department of Phase I Clinical Trial Unit, The First Hospital of Jilin University, Changchun, ChinaView further author information
,
Haijun Lib Guangdong Raynovent Biotech Co., Ltd, Guangzhou, ChinaView further author information
,
Min Wua Department of Phase I Clinical Trial Unit, The First Hospital of Jilin University, Changchun, ChinaORCID Iconhttps://orcid.org/0000-0001-9152-3402View further author information
ORCID Icon,
Hong Zhanga Department of Phase I Clinical Trial Unit, The First Hospital of Jilin University, Changchun, ChinaView further author information
,
Yanhua Dinga Department of Phase I Clinical Trial Unit, The First Hospital of Jilin University, Changchun, ChinaView further author information
,
Yun Pengb Guangdong Raynovent Biotech Co., Ltd, Guangzhou, ChinaView further author information
,
Xiaojiao Lia Department of Phase I Clinical Trial Unit, The First Hospital of Jilin University, Changchun, ChinaView further author information
&
Zhenxiang Yuc Department of Respiratory Medicine, The First Hospital of Jilin University, Changchun, ChinaCorrespondence[email protected]
View further author information
 show all
Pages 1159-1167 | Received 11 Mar 2021, Accepted 14 Oct 2021, Published online: 01 Nov 2021

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Woo-Jin Shin, Seongil Choi & Baik-Lin Seong. (2023) What are the considerations when selecting a model for influenza drug discovery?. Expert Opinion on Drug Discovery 18:1, pages 1-3.
Read now
Jinshen Wang, Yihang Sun & Shuwen Liu. (2022) Emerging antiviral therapies and drugs for the treatment of influenza. Expert Opinion on Emerging Drugs 27:4, pages 389-403.
Read now

Articles from other publishers (1)

Rashmi Kumari, Suresh D. Sharma, Amrita Kumar, Zachary Ende, Margarita Mishina, Yuanyuan Wang, Zackary Falls, Ram Samudrala, Jan Pohl, Paul R. Knight & Suryaprakash Sambhara. (2023) Antiviral Approaches against Influenza Virus. Clinical Microbiology Reviews 36:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.